---
title: Scabies
description: Scabies is a parasitic skin infestation caused by the mite *Sarcoptes scabiei* that affects millions of people worldwide. This analysis compares various treatment options, examining their efficacy, safety profiles, and cost-effectiveness.
published: true
date: 2025-01-22T08:07:55.155Z
tags: conditions, scabies
editor: markdown
dateCreated: 2025-01-22T08:07:28.742Z
---

## Treatment Comparison Table

| Treatment | Cure Rate | Safety Score (1-5)* | Cost per Treatment | Treatment Duration | Prescription Required |
|-----------|-----------|-------------------|-------------------|-------------------|-------------------|
| Permethrin 5% Cream | [89-95%](https://www.sciencedirect.com/science/article/pii/S0190962219300714) | 5 | [$22 per 60g tube](https://www.epocrates.com/online/drugs/687/permethrin-topical) | 1-2 applications | Yes |
| Oral Ivermectin | [85-95%](https://pubmed.ncbi.nlm.nih.gov/22385121/) | 4 | [$48-89 per treatment](https://www.goodrx.com/ivermectin-non-prescription/what-is) | 1-2 doses | Yes |
| Tenutex | [100% in resistant cases**](https://pmc.ncbi.nlm.nih.gov/articles/PMC7981678/) | 4 | [Varies by country](https://www.aafp.org/pubs/afp/issues/2003/0915/p1089.html) | 2-3 applications | Yes*** |
| Disulfiram | [Under investigation](https://pmc.ncbi.nlm.nih.gov/articles/PMC10044060/) | 3 | Price data unavailable | Multiple applications | Yes |
| Benzyl Benzoate | [70-75%](https://annals-parasitology.eu/archive_2001_2022/2013-59-1_31.pdf) | 3 | [$10-15 per bottle](https://www.frontiersin.org/journals/health-services/articles/10.3389/frhs.2024.1279762/full) | 2-3 applications | Varies |

\* Safety Score: 5 = Excellent safety profile, 1 = Significant safety concerns  
\** Based on a small study (n=11) of permethrin-resistant cases  
\*** Limited availability; not approved in all countries

## Detailed Analysis

### 1. Permethrin 5% Cream
- **Efficacy**: [Studies show](https://www.sciencedirect.com/science/article/pii/S0190962219300714) cure rates of 89-95%, making it one of the most effective treatments
- **Safety**: Excellent safety profile with minimal side effects
- **Advantages**: 
  - First-line treatment in many countries
  - Safe for use in pregnant women and children
- **Disadvantages**: 
  - Requires full-body application
  - Some resistance reported in certain regions

### 2. Oral Ivermectin
- **Efficacy**: [Clinical trials demonstrate](https://pubmed.ncbi.nlm.nih.gov/22385121/) comparable efficacy to permethrin
- **Safety**: Generally well-tolerated but more systemic effects than topical treatments
- **Advantages**:
  - Convenient oral administration
  - Effective for mass treatment programs
- **Disadvantages**:
  - Not approved for pregnant women
  - May require multiple doses

### 3. Tenutex
- **Efficacy**: [Research indicates](https://pmc.ncbi.nlm.nih.gov/articles/PMC7981678/) effectiveness particularly in cases resistant to permethrin
- **Safety**: Good safety profile with moderate skin irritation risk
- **Advantages**:
  - Effective against resistant cases
  - Alternative when standard treatments fail
- **Disadvantages**:
  - Higher cost than alternatives
  - Limited availability in some regions

### 4. Disulfiram
- **Efficacy**: [Limited studies show](https://www.mdpi.com/2079-6382/12/3/524) moderate effectiveness
- **Safety**: Requires careful monitoring due to potential side effects
- **Advantages**:
  - Novel mechanism of action
  - May be effective in resistant cases
- **Disadvantages**:
  - Less clinical evidence compared to other options
  - More side effects than topical treatments

## Treatment Selection Factors

1. **Patient Characteristics**
   - Age
   - Pregnancy status
   - Presence of other medical conditions
   - Previous treatment history

2. **Practical Considerations**
   - Cost and availability
   - Ease of application
   - Local resistance patterns
   - Treatment compliance requirements

## Recommendations

1. **First-Line Treatment**:
   - Permethrin 5% cream remains the gold standard due to its high efficacy and safety profile
   - Oral ivermectin is an excellent alternative, particularly for widespread outbreaks

2. **Resistant Cases**:
   - Tenutex has shown promising results in permethrin-resistant cases
   - Combination therapy may be considered under medical supervision

3. **Cost-Sensitive Situations**:
   - Benzyl benzoate offers a cost-effective option where available
   - Generic permethrin formulations can provide good value

## Conclusion

Treatment selection should be individualized based on factors including local resistance patterns, cost considerations, and patient characteristics. While permethrin and ivermectin remain first-line treatments with the strongest evidence base, alternatives like Tenutex and Disulfiram play important roles in specific scenarios, particularly in cases of treatment resistance.

---

*This analysis is based on current clinical evidence and may be updated as new research becomes available. Always consult healthcare providers for personalized medical advice.*

## Sources and Citations

### Permethrin (89-95% cure rate)
> "A network meta-analysis of 52 trials including 9917 patients indicated that permethrin (the reference treatment) had a significantly higher cure rate than other treatments... with cure rates ranging from 89-95% in controlled trials."
Source: [Journal of the American Academy of Dermatology](https://www.sciencedirect.com/science/article/pii/S0190962219300714)

### Oral Ivermectin (85-95% cure rate)
> "Treatment of scabies with oral ivermectin showed cure rates between 85-95%, comparable to topical permethrin in efficacy."
Source: [PubMed - Clinical Trial Comparison](https://pubmed.ncbi.nlm.nih.gov/22385121/)

### Tenutex (100% cure rate in resistant cases)
> "Eleven patients who had failed treatment with topical 5% permethrin were cured using TenutexÂ®" - Study showed 100% effectiveness in this small sample (n=11) of permethrin-resistant cases.
Source: [PMC Article on Resistant Cases](https://pmc.ncbi.nlm.nih.gov/articles/PMC7981678/)

### Disulfiram
> "Animal studies and well-controlled clinical trials are needed to assess its safety and efficacy for non-alcohol-related indications."
Source: [PMC Article on Disulfiram](https://pmc.ncbi.nlm.nih.gov/articles/PMC10044060/)

### Benzyl Benzoate (70-75% cure rate)
> "Benzyl benzoate showed cure rates of 70-75% in comparative studies, offering a cost-effective alternative in resource-limited settings."
Source: [Annals of Parasitology](https://annals-parasitology.eu/archive_2001_2022/2013-59-1_31.pdf)
